Expanding microbiome–gut–brain research could boost mental health in the Global South

Microbiome research is increasingly pointing to the gut–brain axis as an important pathway for mental health, linking microbial communities to neural function through immune signaling, metabolic byproducts, and neuroactive metabolites. Yet most studies that probe this relationship have been conducted in high-income countries (HICs). A new perspective in Nature Mental Health argues that this geographic imbalance is not merely a gap in representation—it may actively skew what scientists think the microbiome–gut–brain axis means for mood, cognition, and brain resilience.

The authors emphasize that environmental exposures vary dramatically across regions—diet composition, sanitation infrastructure, urbanization patterns, early-life factors, and infection burden. These variables can shape microbiome development and function, which in turn can influence host pathways relevant to stress physiology and neuroinflammation. If studies are concentrated in HIC settings, the resulting models may overfit to microbial configurations and environmental contexts that are atypical elsewhere.

In their first argument, the researchers warn that overrepresentation of HIC cohorts could distort our understanding of how the axis operates in real-world mental health risk. For example, microbiome signatures associated with psychiatric outcomes might differ when baseline diets, commensal diversity, or pathogen-driven immune tone vary. The consequence is a partial, context-dependent theory—one that may not translate well to populations in low- and middle-income countries (LMICs).

Second, the paper highlights an opportunity often missed: LMICs may provide “natural experiments” where environmental forces differ in systematic ways. By comparing populations with distinct yet stable exposure profiles, researchers can disentangle which environmental drivers are most influential—whether through changes in fiber fermentation, microbial metabolite availability, or immune modulation.

Third, the authors argue that intervention pipelines could be limited if lifestyle-informed treatments are developed primarily from HIC-derived evidence. Microbiome-targeted approaches—such as diet-based strategies—may require adaptation to local food systems, cultural practices, and existing microbial ecosystems to be effective and equitable.

Importantly, the case is framed as scientific rigor rather than charity alone. Studying the microbiome–gut–brain axis across broader geographies can generate more generalizable mechanisms and better estimates of causal pathways.

The authors conclude that expanding research into the global south is therefore both ethically desirable and methodologically necessary, with the potential to produce mental health benefits that scale beyond the contexts where current evidence was generated.